Sanofi launches innovation and operation centre in China
20/03/2026 14:36
BEIJING, March 20 (Reuters) - French drugmaker Sanofi SASY.PA launched an innovation and operation centre in the southwestern Chinese city of Chengdu on Thursday, the company said in a statement released on its Chinese social media account on Friday. The centre will support the company's R&D efforts, clinical operations, and manufacturing and supply chain services, the statement read. (Reporting by Xiuhao Chen and Ryan Woo, Editing by Louise Heavens) ((Xiuhao.Chen@thomsonreuters.com;))
Recent news on Sanofi SA
See all newsFDA approves expanded use of Sanofi's type 1 diabetes drug (updated)
Brief: FDA Approves Tzield For Pediatric Stage 3 Type I Diabetes
FDA approves Sanofi's drug for stage 3 type 1 diabetes in children
European shares steady as investors weigh US-Iran flare-up (updated)
European shares steady as investors cling to Mideast peace hopes